This comprehensive review and clinical analysis explore the pivotal role of thorax computed tomography (CT) in the context of COVID-19. As the world grapples with the ongoing pandemic, the need for effective diagnostic tools and management strategies remains paramount. This review meticulously examines the impact of thorax CT imaging on the understanding, diagnosis, and clinical management of COVID-19. The review encompasses an extensive analysis of the existing literature, shedding light on the nuances of thorax CT findings in COVID-19 patients. It explores the characteristic imaging features, such as ground-glass opacities, consolidations, and other pulmonary abnormalities, providing insights into the pathophysiology of the disease. Furthermore, the clinical analysis component synthesizes data from diverse studies to elucidate the diagnostic accuracy and sensitivity of thorax CT, particularly in cases where molecular testing may present challenges. The review also delves into the role of thorax CT in early detection, risk stratification, and longitudinal monitoring of patients with COVID-19, offering valuable perspectives for healthcare professionals. Importantly, considerations of radiation exposure and ethical use of thorax CT are addressed, emphasizing the judicious integration of imaging into clinical practice. The article concludes with practical recommendations for optimizing the utility of thorax CT in the broader context of COVID-19 diagnosis and patient care.
| Published in | American Journal of Laboratory Medicine (Volume 9, Issue 2) |
| DOI | 10.11648/j.ajlm.20240902.12 |
| Page(s) | 18-22 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2024. Published by Science Publishing Group |
Thorax Computed Tomography Imaging, SARS-CoV-2, COVID-19, Diagnostic Imaging, Ground-Glass Opacities GGO
| [1] | Thomas C. Kwee, MD, Robert M. Kwee, MD, Chest CT in COVID-19: What the Radiologist Needs to Know, Radiological Society of North America, 2020; 40: 1848–1865. |
| [2] |
World Health Organization. Coronavirus.
https://www.who.int/health-stopics/coronavirus#tab=tab_1 Accessed June 6, 2020. |
| [3] | Koichi Yuki, Miho Fujiogi, Sophia KoutsogiannakiCovid pathophysiology: A review, Clinical Immunology Volume 215, June 2020, 108427. |
| [4] | T. G. Ksiazek, D. Erdman, C. S. Goldsmith, S. R. Zaki, T. Peret, S. Emery, S. Tong, C. Urbani, J. A. Comer, W. Lim, P. E. Rollin, S. F. Dowell, A. E. Ling, C. D. Humphrey, W. J. Shieh, J. Guarner, C. D. Paddock, P. Rota, B. Fields, J. DeRisi, J. Y. Yang, N. Cox, J. M. Hughes, J. W. LeDuc, W. J. Bellini, L. J. Anderson, SW Group. |
| [5] | Wu, Yi-Chi; Chen, Ching-Sung; Chan, Yu-Jiuna,, Journal of the Chinese Medical Association, 2020; 40: 1848–1865. |
| [6] |
World Health Organization. Pneumonia of unknown caus: China. 83(3) 217-220, March 2020 The Lancet. Emerging understandings of 2019- nCoV. Lancet 2020; 395: 311.
https://www.who.int/csr/don/05-january-2020-pneumonia-of-unkown-cause-china/en/ |
| [7] | Drosten C, Gunther S, Preiser W, et al.. Identification of a novel coronavirus in patients with severe acute respiratory syn-drome. N Engl J Med 2003; 348: 1967-1976. |
| [8] |
World Health Organization. WHO announces COVID-19 outbreak a pandemic.
http://www.euro.who.int/en/healthtopics/health-emergencies/coronavirus-covid-19/news/2020/3/who-announces-covid-19-outbreak-a-pandemic Published March 12, 2020. Accessed June 6, 2020. |
| [9] | Thomas C. Kwee, MD, Robert M. Kwee, MD, Chest CT in COVID-19: What the Radiologist Needs to Know, Radiological Society of North America, 2020; 40: 1848–1865. |
| [10] |
Johns Hopkins University School of Medicine. Coronavirus Resource Center.
https://coronavirus.jhu.edu/ Updated June 13, 2020. Accessed June 13, 2020. |
| [11] | Reem Hoteit and Hadi M. Yassine, Properties of SARS- CoV-2 Variants: Epidemiological Impact and Clinical Consequences 2022 Jun 9. |
| [12] | Thanh Le T, Andreadakis Z, Kumar A, et al. The CO-VID-19 vaccine development landscape. Nat Rev Drug Dis-cov 2020; 19(5): 305–306. |
| [13] | C. Huang, Y. Wang, X. Li, L. Ren, J. Zhao, Y. Hu, L. Zhang, G. Fan, J. Xu, X. Gu, Z. Cheng, T. Yu, J. Xia, Y. Wei, W. Wu, X. Xie, W. Yin, H. Li, M. Liu, Y. Xiao, H. Gao, L. Guo, J. Xie, G. Wang, R. Jiang, Z. Gao, Q. Jin, J. Wang, B. Cao. |
| [14] | Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaLancet, 395 (2020), pp. 497-50. Saborni Chakraborty, Vamsee Mallajosyula Cristina M. Tato c, Gene S. Tan d e, Taia T. Wang SARS-CoV-2 vaccines in advanced clinical trials: Where do we stand 20 January 2021. |
| [15] | Kim EA, Lee KS, Primack SL, Yoon HK, Byun HS, Kim TS, Suh GY, Kwon OJ, Han J. Viral pneumonias in adults: radiologic and pathologic findings. Radiographics. 2002; 22: S137-S149. |
| [16] | ZhaoW, Zhong Z, Xie X, Yu Q, Liu J. Relation Between Chest CT Findings and Clinical Conditions of Coronavirus Disease (COVID-19) Pneumonia: A Multicenter Study. AJR Am J Roentgenol. 2020; 214: 1072-1077. |
| [17] | Wu Z., McGoogan J. M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72314 cases from the Chinese center for disease control and prevention. J Am Med Assoc. 2020 |
| [18] | Koichi Yuki, Miho Fujiogi, Sophia KoutsogiannakiCovid pathophysiology: A review, Clinical Immunology Volume 215, June 2020, 108427. |
| [19] | Felsenstein S., Herbert J. A., McNamara P. S., Hedrich C. M. COVID-19: Immunology and treatment options. Clin Immunol. 2020; 215: 108448. |
| [20] | Giamarellos-Bourboulis E. J., Netea M. G., Rovina N., et al. Complex immune dysregulation in COVID-19 patients with se-vere respiratory failure. Cell Host Microbe. 2020; 27: 992–1000 e1003. |
| [21] | Qin C., Zhou L., Hu Z., et al. Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in wuhan, China. Clin Infect Dis. 2020; 71: 762–768. |
| [22] | Gianluca Pontone, a, Stefano Scafuri, b Maria Elisabetta Mancini, a Cecilia Agalbato, c Marco Guglielmo, a Andrea Bag-giano, a Giuseppe Muscogiuri, a Laura Fusini, a Daniele Andreini, a, d Saima Mushtaq, a Edoardo Conte, a Andrea Annoni, a Al-berto Formenti, a Antonio Giulio Gennari, e Andrea I. Guaricci, f Mark R. Rabbat, g, h Giulio Pompilio, a, d Mauro Pepi, a and Alexia RossiI Role of computed tomography in COVID-19 021 January-February; 15(1): |
| [23] | Marina Carotti, Fausto Salaffi, Piercarlo Sarzi-Puttini, Andrea Agostini, Alessandra Borgheresi, Davide Minorati, Massimo Galli, Daniela Marotto, and Andrea Giovagnoni. Chest CT features of corana virus disease 2019 [COVID 19] pneumonia: Key points for radiologista. published june 4 2020. |
APA Style
Maqbool, Y. (2024). Imaging the Impact: Computed Tomography Thorax in COVID-19 - A Comprehensive Review and Clinical Analysis. American Journal of Laboratory Medicine, 9(2), 18-22. https://doi.org/10.11648/j.ajlm.20240902.12
ACS Style
Maqbool, Y. Imaging the Impact: Computed Tomography Thorax in COVID-19 - A Comprehensive Review and Clinical Analysis. Am. J. Lab. Med. 2024, 9(2), 18-22. doi: 10.11648/j.ajlm.20240902.12
Share This Article
Twitter
Linked In
Facebook
Copy
Download@article{10.11648/j.ajlm.20240902.12,
author = {Yasmeena Maqbool},
title = {Imaging the Impact: Computed Tomography Thorax in COVID-19 - A Comprehensive Review and Clinical Analysis
},
journal = {American Journal of Laboratory Medicine},
volume = {9},
number = {2},
pages = {18-22},
doi = {10.11648/j.ajlm.20240902.12},
url = {https://doi.org/10.11648/j.ajlm.20240902.12},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajlm.20240902.12},
abstract = {This comprehensive review and clinical analysis explore the pivotal role of thorax computed tomography (CT) in the context of COVID-19. As the world grapples with the ongoing pandemic, the need for effective diagnostic tools and management strategies remains paramount. This review meticulously examines the impact of thorax CT imaging on the understanding, diagnosis, and clinical management of COVID-19. The review encompasses an extensive analysis of the existing literature, shedding light on the nuances of thorax CT findings in COVID-19 patients. It explores the characteristic imaging features, such as ground-glass opacities, consolidations, and other pulmonary abnormalities, providing insights into the pathophysiology of the disease. Furthermore, the clinical analysis component synthesizes data from diverse studies to elucidate the diagnostic accuracy and sensitivity of thorax CT, particularly in cases where molecular testing may present challenges. The review also delves into the role of thorax CT in early detection, risk stratification, and longitudinal monitoring of patients with COVID-19, offering valuable perspectives for healthcare professionals. Importantly, considerations of radiation exposure and ethical use of thorax CT are addressed, emphasizing the judicious integration of imaging into clinical practice. The article concludes with practical recommendations for optimizing the utility of thorax CT in the broader context of COVID-19 diagnosis and patient care.
},
year = {2024}
}
TY - JOUR T1 - Imaging the Impact: Computed Tomography Thorax in COVID-19 - A Comprehensive Review and Clinical Analysis AU - Yasmeena Maqbool Y1 - 2024/08/30 PY - 2024 N1 - https://doi.org/10.11648/j.ajlm.20240902.12 DO - 10.11648/j.ajlm.20240902.12 T2 - American Journal of Laboratory Medicine JF - American Journal of Laboratory Medicine JO - American Journal of Laboratory Medicine SP - 18 EP - 22 PB - Science Publishing Group SN - 2575-386X UR - https://doi.org/10.11648/j.ajlm.20240902.12 AB - This comprehensive review and clinical analysis explore the pivotal role of thorax computed tomography (CT) in the context of COVID-19. As the world grapples with the ongoing pandemic, the need for effective diagnostic tools and management strategies remains paramount. This review meticulously examines the impact of thorax CT imaging on the understanding, diagnosis, and clinical management of COVID-19. The review encompasses an extensive analysis of the existing literature, shedding light on the nuances of thorax CT findings in COVID-19 patients. It explores the characteristic imaging features, such as ground-glass opacities, consolidations, and other pulmonary abnormalities, providing insights into the pathophysiology of the disease. Furthermore, the clinical analysis component synthesizes data from diverse studies to elucidate the diagnostic accuracy and sensitivity of thorax CT, particularly in cases where molecular testing may present challenges. The review also delves into the role of thorax CT in early detection, risk stratification, and longitudinal monitoring of patients with COVID-19, offering valuable perspectives for healthcare professionals. Importantly, considerations of radiation exposure and ethical use of thorax CT are addressed, emphasizing the judicious integration of imaging into clinical practice. The article concludes with practical recommendations for optimizing the utility of thorax CT in the broader context of COVID-19 diagnosis and patient care. VL - 9 IS - 2 ER -
Faculty of Health and Allied Sciences, Guru Kashi University Talwandi Sabo Bathinda, Punjab, India
Information